CEENU

Product Overview

CEENU (Lomustine) is a prescription medication classified as an alkylating agent, primarily utilized in oncology for the management of various neoplastic conditions. As a chemotherapy treatment, it works by interfering with the replication of DNA and RNA, thereby inhibiting the growth and proliferation of cancer cells.

Primary Uses:

• Treatment of primary and metastatic brain tumors.
• Management of Hodgkin's lymphoma as part of combination chemotherapy regimens.

Key Benefits:

• Lipid-soluble formulation, allowing the active ingredient to effectively cross the blood-brain barrier for central nervous system malignancies.
• Administered orally, providing a convenient alternative to intravenous chemotherapy in specific therapeutic protocols.
• Well-established clinical history in oncology treatment regimens.

Essential Characteristics:

• Active Ingredient: Lomustine.
• Drug Class: Nitrosourea (alkylating agent).
• Administration: Oral capsule.
• Safety Information: This medication requires strict medical supervision by a qualified oncologist. Blood counts, liver function, and other baseline laboratory tests are necessary before and during treatment to monitor potential bone marrow suppression and other systemic effects.